Adipose tissue-derived stem cell therapy for prevention and treatment of erectile dysfunction in a rat model of Peyronie's disease
- PMID: 24574095
- DOI: 10.1111/j.2047-2927.2013.00181.x
Adipose tissue-derived stem cell therapy for prevention and treatment of erectile dysfunction in a rat model of Peyronie's disease
Abstract
Peyronie's disease (PD) is a localized connective tissue disorder that involves the tunica albuginea (TA) of the penis. While surgical correction remains the gold standard, the search for an effective and less invasive therapy continues. The objective of this study was to evaluate the effects of intratunical injection of adipose tissue-derived stem cells (ADSCs) for the prevention and treatment of erectile dysfunction in a rat model of PD. Twenty-four male Sprague-Dawley rats (300-350 g) were randomly divided into four groups: sham, PD, PD + ADSC (prevention) and PD + ADSC (treatment). All rats underwent penile injections into the TA with 50 μL vehicle (sham) or 0.5 μg transforming growth factor (TGF)-β1 (remaining groups). The ADSC groups received intratunical injections with 0.5 million rat-labelled ADSCs on day 0 (prevention) or day 30 (treatment). Forty-five days following TGF-β1 injection, rats underwent cavernous nerve stimulation (CNS) with total intracavernous-to-mean arterial pressure ratio (ICP/MAP) and total ICP recorded to measure response to therapy. Tissues were evaluated histologically and for mRNA expression of tissue inhibitors of metalloproteinases (TIMPs), matrix metalloproteinases (MMPs) and zymographic activity of MMPs. Statistical analysis was performed by analysis of variance followed by the Tukey test for post hoc comparisons. In both prevention and treatment groups, intratunical injection of ADSCs resulted in significantly higher ICP/MAP and total ICP in response to CNS compared with the PD group. Local injection of ADSCs prevented and/or reduced Peyronie's-like changes by decreasing the expression of TIMPs, and stimulating expression and activity of MMPs. This study documents the preventive and therapeutic benefits of ADSC on penile fibrosis and erectile function in an animal model of PD.
Keywords: Peyronie's disease; erectile function; fibrosis; stem cells; tunica albuginea.
© 2014 American Society of Andrology and European Academy of Andrology.
Similar articles
-
Intratunical Injection of Genetically Modified Adipose Tissue-Derived Stem Cells with Human Interferon α-2b for Treatment of Erectile Dysfunction in a Rat Model of Tunica Albugineal Fibrosis.J Sex Med. 2015 Jul;12(7):1533-44. doi: 10.1111/jsm.12916. Epub 2015 Jun 10. J Sex Med. 2015. PMID: 26062100 Free PMC article.
-
Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease.Eur Urol. 2013 Mar;63(3):551-60. doi: 10.1016/j.eururo.2012.09.034. Epub 2012 Sep 24. Eur Urol. 2013. PMID: 23040209 Free PMC article.
-
Intratunical injection of human urine-derived stem cells derived exosomes prevents fibrosis and improves erectile function in a rat model of Peyronie's disease.Andrologia. 2020 Dec;52(11):e13831. doi: 10.1111/and.13831. Epub 2020 Sep 28. Andrologia. 2020. PMID: 32986908
-
Management of Peyronie's disease--a review.World J Urol. 2001 Aug;19(4):244-50. World J Urol. 2001. PMID: 11550782 Review.
-
Peyronie's disease: epidemiology, diagnosis, and management.Curr Med Res Opin. 2014 Jan;30(1):113-20. doi: 10.1185/03007995.2013.842544. Epub 2013 Sep 30. Curr Med Res Opin. 2014. PMID: 24040888 Review.
Cited by
-
Advances in stem cell therapy for the treatment of Peyronie's disease.Intractable Rare Dis Res. 2020 Feb;9(1):10-13. doi: 10.5582/irdr.2019.01130. Intractable Rare Dis Res. 2020. PMID: 32201669 Free PMC article. Review.
-
Peyronie's disease: What's around the bend?Indian J Urol. 2016 Jan-Mar;32(1):6-14. doi: 10.4103/0970-1591.173107. Indian J Urol. 2016. PMID: 26941488 Free PMC article. Review.
-
Recent advances in stem cell therapy for erectile dysfunction: a narrative review.Expert Opin Biol Ther. 2023 Jan-Jun;23(6):565-573. doi: 10.1080/14712598.2023.2203811. Epub 2023 Apr 20. Expert Opin Biol Ther. 2023. PMID: 37078259 Free PMC article. Review.
-
Treatment with Autologous Adipose-derived Regenerative Cells for Peyronie's Disease in Men: The Straight @head Pilot Study.Eur Urol Open Sci. 2024 Dec 31;71:180-186. doi: 10.1016/j.euros.2024.12.005. eCollection 2025 Jan. Eur Urol Open Sci. 2024. PMID: 39845743 Free PMC article.
-
Evidence of restorative therapies in the treatment of Peyronie disease: A narrative review.Int Braz J Urol. 2024 Nov-Dec;50(6):703-713. doi: 10.1590/S1677-5538.IBJU.2024.9920. Int Braz J Urol. 2024. PMID: 39133793 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical